Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation

Journal of Pediatric Gastroenterology and Nutrition

Volumn 42, Issue 1, 2006, Pages 46-52

  De Lisle, Robert C ^a   Roach, Eileen A ^a   Norkina, Oxana ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Bacterial overgrowth; Cystic fibrosis; Intestine; Mucin

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; METRONIDAZOLE; MUCIN 2; MUCIN 3; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; CONTROLLED STUDY; CYSTIC FIBROSIS; ERADICATION THERAPY; FEMALE; GENE; GENE EXPRESSION; GOBLET CELL; INTESTINE CRYPT; INTESTINE FLORA; MALE; MORPHOMETRICS; MOUSE; MUCUS; MUCUS SECRETION; NONHUMAN; NULL ALLELE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; WILD TYPE;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; CIPROFLOXACIN; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; FEMALE; INTESTINE, SMALL; MALE; METRONIDAZOLE; MICE; MICE, INBRED C57BL; MICE, INBRED CFTR; MUCINS; MUCUS; PERIODIC ACID-SCHIFF REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 30344455943     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000189322.34582.3e     Document Type: Article

References (35)

1. Casaccia G, Trucchi A, Nahom A, et al. The impact of cystic fibrosis on neonatal intestinal obstruction: the need for prenatal/neonatal screening. Pediatr Surg Int 2003;19:75-8.
2. Eggermont E. Gastrointestinal manifestations in cystic fibrosis. Eur J Gastroenterol Hepatol 1996;8:731-8.
3. Flemström G, Hällgren A, Nylander O, et al. Adherent surface mucus gel restricts diffusion of macromolecules in rat duodenum in vivo. Am J Physiol Gastrointest Liver Physiol 1999;277:G375-82.
4. Barraclough M, Taylor CJ. Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption. J Pediatr Gastroenterol Nutr 1996;23:45-50.
5. Raia V, Maiuri L, De Ritis G, et al. Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 2000;47:344-50.
6. Smyth RL, Croft NM, O'Hea U, et al. Intestinal inflammation in cystic fibrosis. Arch Dis Child 2000;82:394-9.
7. O'Brien S, Mulcahy H, Fenlon H, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-41.
8. Lewindon PJ, Robb TA, Moore DJ, et al. Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health 1998;34:79-82.
9. Fridge J, Castillo R, Conrad C, et al. Small bowel bacterial overgrowth in cystic fibrosis [Abstract]. Gastroenterology 2005; 128:S1205.
10. Borowitz D, Durie PR, Clarke LL, et al. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 2005;41:273-285.
11. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 2004;72:6040-9.
12. Clarke LL, Gawenis LR, Bradford EM, et al. Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am J Physiol Gastrointest Liver Physiol 2004;286:G1050-8.
13. Norkina O, Kaur S, Ziemer D, et al. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2004;286:G1032-41.
14. Dohrman A, Miyata S, Gallup M, et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta Mol Basis Dis 1998;1406:251-9.
15. Knight PA, Pemberton AD, Robertson KA, et al. Expression profiling reveals novel innate and inflammatory responses in the jejunal epithelial compartment during infection with Trichinella spiralis. Infect Immun 2004;72:6076-8.
16. Lievin-Le Moal V, Servin AL, Coconnier-Polter MH. The increase in mucin exocytosis and the upregulation of MUC genes encoding for membrane-bound mucins induced by the thiol-activated exotoxin listeriolysin O is a host cell defense response that inhibits the cell-entry of Listeria monocytogenes. Cell Microbiol 2005;7:1035-48.
17. Leiper K, Campbell BJ, Jenkinson MD, et al. Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis. Clin Sci (Lond) 2001;101:395-402.
18. Adler KB, Li YH. Airway epithelium and mucus: intracellular signaling pathways for gene expression and secretion. Am J Respir Cell Mol Biol 2001;25:397-400.
19. Halm DR, Halm ST. Secretagogue response of goblet cells and columnar cells in human colonic crypts. Am J Physiol 1999;277:C501-22.
20. Singh W, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Gastroenterol Rep 2003;5:365-72.
21. Eckman EA, Cotton CU, Kube DM, et al. Dietary changes improve survival of CFTR S489X homozygous mutant mouse. Am J Physiol Lung Cell Mol Physiol 1995;269:L625-30.
22. Hinojosa-Kurtzberg AM, Johansson MEV, Madsen CS, et al. Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice. Am J Physiol Gastrointest Liver Physiol 2003;284:G853-62.
23. Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci U S A 2003;100:10452-9.
24. Clarke LL, Stien X, Walker NM. Intestinal bicarbonate secretion in cystic fibrosis mice. JOP (www.joplink.net) 2001;2:263-7.
25. Kaur S, Norkina O, Ziemer D, et al. Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. Am J Physiol Gastrointest Liver Physiol 2004;286:G480-9.
26. De Lisle RC, Isom KS, Ziemer D, et al. Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse. Am J Physiol Gastrointest Liver Physiol 2001;281:G899-906.
27. McNamara N, Basbaum C. Signaling networks controlling mucin production in response to Gram-positive and Gram-negative bacteria. Glycoconj J 2001;18:715-22.
28. Parmley RR, Gendler SJ. Cystic fibrosis mice lacking muc1 have reduced amounts of intestinal mucus. J Clin Invest 1998;102:1798-806.
29. Mailleau C, Paul A, Colin M, et al. Glycoconjugate metabolism in a cystic fibrosis knockout mouse model. Mol Genet Metab 2001;72:122-31.
30. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, et al. Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalphal-2 glycosyltransferase. Biochem J 2002;367:609-16.
31. Cucchiara S, Falconieri P, Di Nardo G, et al. New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age. Dig Liver Dis 2002;34(Suppl):S44-7.
32. Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 2001;29-40.
33. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005;51(Suppl):1-22.
34. Castagliuolo I, Wershil BK, Karalis K, et al. Colonic mucin release in response to immobilization stress is mast cell dependent. Am J Physiol 1998;274:G1094-100.
35. Jeffery P, Zhu J. Mucin-producing elements and inflammatory cells. Novartis Found Symp 2002;248:51-68.